Gemmer Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-28
| Closed | -$15K | – | 570 |
|
|
2022
Q1 | $15K | Sell |
28
-2
| -7% | -$1.05K | ﹤0.01% | 574 |
|
|
2021
Q4 | $20K | Buy |
30
+1
| +3% | +$628 | ﹤0.01% | 511 |
|
|
2021
Q3 | $18K | Hold |
29
| – | – | ﹤0.01% | 508 |
|
|
2021
Q2 | $18K | Hold |
29
| – | – | ﹤0.01% | 573 |
|
|
2021
Q1 | $14K | Sell |
29
-121
| -81% | -$60.6K | ﹤0.01% | 635 |
|
|
2020
Q4 | $75K | Hold |
150
| – | – | 0.01% | 174 |
|
|
2020
Q3 | $59K | Hold |
150
| – | – | 0.01% | 184 |
|
|
2020
Q2 | $50K | Hold |
150
| – | – | 0.01% | 198 |
|
|
2020
Q1 | $36K | Hold |
150
| – | – | 0.01% | 218 |
|
|
2019
Q4 | $39K | Hold |
150
| – | – | 0.01% | 235 |
|
|
2019
Q3 | $41K | Hold |
150
| – | – | 0.01% | 222 |
|
|
2019
Q2 | $41K | Hold |
150
| – | – | 0.01% | 211 |
|
|
2019
Q1 | $34K | Hold |
150
| – | – | 0.01% | 265 |
|
|
2018
Q4 | $28K | Hold |
150
| – | – | 0.01% | 260 |
|
|
2018
Q3 | $37K | Sell |
150
-88
| -37% | -$21.4K | 0.01% | 228 |
|
|
2018
Q2 | $52K | Hold |
238
| – | – | 0.02% | 178 |
|
|
2018
Q1 | $46K | Hold |
238
| – | – | 0.02% | 199 |
|
|
2017
Q4 | $37K | Hold |
238
| – | – | 0.01% | 239 |
|
|
2017
Q3 | $37K | Hold |
238
| – | – | 0.01% | 217 |
|
|
2017
Q2 | $38K | Hold |
238
| – | – | 0.02% | 218 |
|
|
2017
Q1 | $37K | Hold |
238
| – | – | 0.02% | 206 |
|
|
2016
Q4 | $28K | Hold |
238
| – | – | 0.01% | 246 |
|
|
2016
Q3 | $27K | Hold |
238
| – | – | 0.01% | 252 |
|
|
2016
Q2 | $22K | Hold |
238
| – | – | 0.01% | 278 |
|
|
2016
Q1 | $18K | Buy |
238
+50
| +27% | +$3.6K | 0.01% | 340 |
|
|
2015
Q4 | $14K | Sell |
188
-12
| -6% | -$856 | 0.01% | 420 |
|
|
2015
Q3 | $15K | Buy |
200
+12
| +6% | +$860 | 0.01% | 392 |
|
|
2015
Q2 | $12K | Sell |
188
-8
| -4% | -$554 | 0.01% | 518 |
|
|
2015
Q1 | $15K | Hold |
196
| – | – | 0.01% | 437 |
|
|
2014
Q4 | $15K | Hold |
196
| – | – | 0.01% | 410 |
|
|
2014
Q3 | $12K | Hold |
196
| – | – | 0.01% | 484 |
|
|
2014
Q2 | $13K | Hold |
196
| – | – | 0.01% | 473 |
|
|
2014
Q1 | $12K | Buy |
+196
| New | +$11.7K | 0.01% | 487 |
|
Other funds holding IDXX
Gemmer Asset Management's IDXX Position: Q2 2022 in Review
Gemmer Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 28 shares — an estimated $15K sold.
Gemmer Asset Management first reported a position in IDXX in Q1 2014 and held it in 33 quarters. The position peaked at $75K in Q4 2020. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.
- Gemmer Asset Management reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
- Gemmer Asset Management sold 28 Idexx Laboratories shares in Q2 2022, an estimated $15K.
- Gemmer Asset Management first reported a position in Idexx Laboratories in Q1 2014 and held it in 33 quarters.
- Gemmer Asset Management's Idexx Laboratories position peaked at $75K in Q4 2020.
- 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.
Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.